exhibited a growth factor requirement as the result of cysH, icdA, metE, or purB mutation.
Resistance in all of these mutants required a functional AcrAB-TolC efflux pump, but the
EmrAB-TolC pump played no obvious role. Transcription of acrAB was increased in each
type of Nalr mutant. In the icdA and purB mutants, each of the known signaling pathways
appeared to be used in activating the AcrAB-TolC pump. The metabolites that accumulate …